Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Hillert

Showing results (11-20 of 305) with videos related to

Pageof 31
Sort By:
Journal of Neuroimmunology|October 5, 2007
Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosisFrida Lundmark, Kristina Duvefelt, Jan Hillert
Plos One|August 27, 2013
Considerations for subgroups and phenocopies in complex disease geneticsRyan Ramanujam, S Ramanujam, Jan Hillert
Neurology|December 1, 2020
Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort studyStefanie Binzer, Ali Manouchehrinia, Jan Hillert
Multiple Sclerosis and Related Disorders|May 18, 2024
Concomitant autoimmunity and risk of multiple sclerosis disability worseningStefanie Binzer, Jan Hillert, Ali Manouchehrinia
Acta Neurologica Scandinavica|March 22, 2021
Socioeconomic consequences of multiple sclerosis-A systematic literature reviewAndrius Kavaliunas, Virginija Danylaite Karrenbauer, Jan Hillert
Neurology|May 17, 2019
Long-term disability progression of pediatric-onset multiple sclerosisKyla A McKay, Jan Hillert, Ali Manouchehrinia
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosisWen-Xin Huang, Ping Huang, Jan Hillert
Journal of Neuroimmunology|January 1, 2008
The interleukin 23 receptor gene in multiple sclerosis: a case-control studyIzaura M Roos, Ingrid Kockum, Jan Hillert
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 27, 2017
Comparative effectiveness of rituximab relative to IFN-β or glatiramer acetate in relapsing-remitting MS from the Swedish MS registryTim Spelman, Thomas Frisell, Fredrik Piehl, et al.
Journal of Neuroimmunology|March 31, 2009
HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosisKerstin Imrell, Eva Greiner, Jan Hillert, et al.
Pageof 31

Showing results (11-20 of 305) with videos related to

Sort By:
Pageof 31
Journal of Neuroimmunology|October 5, 2007
Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosisFrida Lundmark, Kristina Duvefelt, Jan Hillert
Plos One|August 27, 2013
Considerations for subgroups and phenocopies in complex disease geneticsRyan Ramanujam, S Ramanujam, Jan Hillert
Neurology|December 1, 2020
Author response: Disability worsening among persons with multiple sclerosis and depression: A Swedish cohort studyStefanie Binzer, Ali Manouchehrinia, Jan Hillert
Multiple Sclerosis and Related Disorders|May 18, 2024
Concomitant autoimmunity and risk of multiple sclerosis disability worseningStefanie Binzer, Jan Hillert, Ali Manouchehrinia
Acta Neurologica Scandinavica|March 22, 2021
Socioeconomic consequences of multiple sclerosis-A systematic literature reviewAndrius Kavaliunas, Virginija Danylaite Karrenbauer, Jan Hillert
Neurology|May 17, 2019
Long-term disability progression of pediatric-onset multiple sclerosisKyla A McKay, Jan Hillert, Ali Manouchehrinia
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 9, 2004
Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosisWen-Xin Huang, Ping Huang, Jan Hillert
Journal of Neuroimmunology|January 1, 2008
The interleukin 23 receptor gene in multiple sclerosis: a case-control studyIzaura M Roos, Ingrid Kockum, Jan Hillert
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 27, 2017
Comparative effectiveness of rituximab relative to IFN-β or glatiramer acetate in relapsing-remitting MS from the Swedish MS registryTim Spelman, Thomas Frisell, Fredrik Piehl, et al.
Journal of Neuroimmunology|March 31, 2009
HLA-DRB115 and cerebrospinal-fluid-specific oligoclonal immunoglobulin G bands lower age at attainment of important disease milestones in multiple sclerosisKerstin Imrell, Eva Greiner, Jan Hillert, et al.
Pageof 31